|
مقاله
|
Abstract
|
|
|
Title:
|
A novel NOD2-associated mutation and variant Blau syndrome: phenotype and molecular analysis
|
Author(s):
|
Nazanin Ebrahimiadib, Khawla Abu Samra, Aaron M. Domina Ph.D., Ethan R. Stiles, Roger Ewer, Charlie P. Bocian, C. Stephen Foster MD, FACS, FACR
|
Presentation Type:
|
Oral
|
Subject:
|
Immunology/Microbiology
|
Others:
|
|
Presenting Author:
|
|
Name:
|
Nazanin Ebrahimi adib
|
Affiliation :(optional)
|
Tehran University of Medical Sciences
|
E mail:
|
nazanin.ebrahimiadib@gmail.com
|
Phone:
|
021-22594802
|
Mobile:
|
09032694051
|
|
|
Purpose:
|
To describe the clinical and molecular implications of a novel mutation in the NOD2/ CARD15 gene on a family and its seven affected members.
|
Methods:
|
We reviewed the clinical presentations of family members who came to our center for refractory uveitis. Genetic testing and molecular testing was performed.
|
Results:
|
All affected members had adult onset recurrent non-granulomatous panuveitis. The inheritance pattern suggested an autosomal dominant disease and genetic analysis identified a novel mutation in the NOD2 gene that converted amino acid 600 from glutamate to alanine (E600A). Transfection of the E600A NOD2 into Human Embryonic Kidney-293 (HEK293) cells revealed constitutive activation and a reduced ability to respond to the NOD2 ligand, muramyl dipeptide (MDP) as compared to wild type NOD2.
|
Conclusion:
|
The E600A mutation in the NOD2 gene may confer a higher penetrance of uveitis but a later onset of milder forms of non-ocular involvement.
|
Attachment:
|
|
|